Cargando…

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System

SIMPLE SUMMARY: There is growing evidence for the essential prognostic role of systemic inflammation within the tumor microenvironment (TME) and the nutritional status in cancer patients. Inflammation-based risk scores such as the Glasgow-Prognostic-Score (GPS), composed of C-reactive protein (CRP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebauer, Niklas, Ziehm, Maria, Gebauer, Judith, Riecke, Armin, Meyhöfer, Sebastian, Kulemann, Birte, von Bubnoff, Nikolas, Steinestel, Konrad, Bauer, Arthur, Witte, Hanno M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656405/ https://www.ncbi.nlm.nih.gov/pubmed/36358883 http://dx.doi.org/10.3390/cancers14215465

Ejemplares similares

Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study
por: Masui, Toshihiko, et al.
Publicado: (2020)

The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Mohamed, Amr, et al.
Publicado: (2022)

Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022)

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation
por: Witte, Hanno M., et al.
Publicado: (2020)

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014
por: Garcia-Carbonero, R., et al.
Publicado: (2014)

The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)
por: Krieg, Sarah, et al.
Publicado: (2023)

Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms
por: Jeong, Sun Young, et al.
Publicado: (2023)

Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
por: Xue, Mingzhan, et al.
Publicado: (2017)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate
por: Witte, Hanno M., et al.
Publicado: (2020)

Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are
por: Rossi, Roberta Elisa, et al.
Publicado: (2022)

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
por: Bauer, Arthur, et al.
Publicado: (2022)

An 11-year retrospective study: clinicopathological and survival analysis of gastro-entero-pancreatic neuroendocrine neoplasm
por: Liu, Hua, et al.
Publicado: (2020)

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
por: Milione, Massimo, et al.
Publicado: (2019)

Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias
por: Albers, Max B., et al.
Publicado: (2020)

A tool to predict survival in stage IV entero-pancreatic NEN
por: Tarquini, M., et al.
Publicado: (2020)

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
por: Olschewski, Vito, et al.
Publicado: (2021)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Kwekkeboom, D. J., et al.
Publicado: (2003)

Gastro-Entero-Colitis of Infancy and Childhood
por: Christian, G. W.
Publicado: (1892)

Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
por: Ooki, Akira, et al.
Publicado: (2023)

Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia
por: Marasco, Matteo, et al.
Publicado: (2023)

Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
por: Thomas, Katharine, et al.
Publicado: (2020)

The effect of alcohol on gastro-entero-pancreatic hormones.
por: Henry, R. W., et al.
Publicado: (1981)

Defining Tumor Microenvironment as a Possible Target for Effective GEP-NENs Immunotherapy—A Systematic Review
por: Chmiel, Paulina, et al.
Publicado: (2023)

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
por: Künstner, Axel, et al.
Publicado: (2022)

Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
por: Gebauer, Niklas, et al.
Publicado: (2021)

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
por: Bocchini, Martine, et al.
Publicado: (2020)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
por: Casey, Ruth T, et al.
Publicado: (2020)

Resection of the primary tumor improves survival in patients with gastro‐entero‐pancreatic neuroendocrine neoplasms with liver metastases: A SEER‐based analysis
por: Zheng, Mengzhen, et al.
Publicado: (2019)

Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
por: Rosery, Vivian, et al.
Publicado: (2022)

Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms—A Single-Center Retrospective Outcome Analysis
por: Lindner, Kirsten, et al.
Publicado: (2021)

Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients
por: Witte, Hanno M., et al.
Publicado: (2020)

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
por: Ferrata, Martina, et al.
Publicado: (2019)

Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study
por: Qureshi, Sheharyar A, et al.
Publicado: (2016)

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
por: González-Flores, E., et al.
Publicado: (2018)

Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging
por: Danti, Ginevra, et al.
Publicado: (2021)

Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)
por: Kong, Grace, et al.
Publicado: (2023)

Peptide Receptor Radionuclide Therapy with [(177)Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions
por: del Olmo-García, Maria I., et al.
Publicado: (2022)

Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
por: Hertel, Nadine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjih7nco99c5u502bo76ijv6b7